Morgan Stanley’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.16M | Buy |
314,410
+28,811
| +10% | +$198K | ﹤0.01% | 4650 |
|
2025
Q1 | $823K | Sell |
285,599
-1,246,133
| -81% | -$3.59M | ﹤0.01% | 5098 |
|
2024
Q4 | $7.2M | Buy |
1,531,732
+1,181,047
| +337% | +$5.55M | ﹤0.01% | 3676 |
|
2024
Q3 | $1.25M | Sell |
350,685
-884,128
| -72% | -$3.16M | ﹤0.01% | 4912 |
|
2024
Q2 | $7.66M | Buy |
1,234,813
+77,676
| +7% | +$482K | ﹤0.01% | 3534 |
|
2024
Q1 | $10.9M | Sell |
1,157,137
-1,280,981
| -53% | -$12.1M | ﹤0.01% | 3281 |
|
2023
Q4 | $16.5M | Buy |
2,438,118
+1,526,247
| +167% | +$10.3M | ﹤0.01% | 3514 |
|
2023
Q3 | $4.05M | Sell |
911,871
-192,003
| -17% | -$852K | ﹤0.01% | 3899 |
|
2023
Q2 | $3.64M | Sell |
1,103,874
-58,494
| -5% | -$193K | ﹤0.01% | 3992 |
|
2023
Q1 | $3.31M | Sell |
1,162,368
-11,243
| -1% | -$32K | ﹤0.01% | 4108 |
|
2022
Q4 | $8.54M | Sell |
1,173,611
-26,691
| -2% | -$194K | ﹤0.01% | 3228 |
|
2022
Q3 | $9.71M | Buy |
1,200,302
+21,346
| +2% | +$173K | ﹤0.01% | 3014 |
|
2022
Q2 | $5.78M | Buy |
1,178,956
+70,532
| +6% | +$346K | ﹤0.01% | 3629 |
|
2022
Q1 | $26.2M | Buy |
1,108,424
+1,018,874
| +1,138% | +$24.1M | ﹤0.01% | 1836 |
|
2021
Q4 | $1.58M | Buy |
89,550
+4,539
| +5% | +$80.3K | ﹤0.01% | 4748 |
|
2021
Q3 | $2.4M | Buy |
85,011
+12,715
| +18% | +$359K | ﹤0.01% | 4414 |
|
2021
Q2 | $757K | Buy |
72,296
+4,491
| +7% | +$47K | ﹤0.01% | 5247 |
|
2021
Q1 | $799K | Sell |
67,805
-31,093
| -31% | -$366K | ﹤0.01% | 4863 |
|
2020
Q4 | $1.16M | Buy |
98,898
+67,249
| +212% | +$787K | ﹤0.01% | 4579 |
|
2020
Q3 | $251K | Sell |
31,649
-9,401
| -23% | -$74.6K | ﹤0.01% | 4987 |
|
2020
Q2 | $751K | Buy |
41,050
+11,902
| +41% | +$218K | ﹤0.01% | 4375 |
|
2020
Q1 | $348K | Buy |
29,148
+15,532
| +114% | +$185K | ﹤0.01% | 4584 |
|
2019
Q4 | $226K | Buy |
13,616
+10,163
| +294% | +$169K | ﹤0.01% | 5363 |
|
2019
Q3 | $23K | Buy |
+3,453
| New | +$23K | ﹤0.01% | 5963 |
|